ZBTB37
geneOn this page
Also known as MGC2629ZNF908
Summary
ZBTB37 (zinc finger and BTB domain containing 37, HGNC:28365) is a protein-coding gene on chromosome 1q25.1, encoding Zinc finger and BTB domain-containing protein 37 (Q5TC79). May be involved in transcriptional regulation.
Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in negative regulation of transcription by RNA polymerase II; regulation of cytokine production; and regulation of immune system process. Predicted to be located in chromatin. Predicted to be active in nucleoplasm.
Source: NCBI Gene 84614 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 50 total
- Phenotypes (HPO): 1
- MANE Select transcript:
NM_001122770
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28365 |
| Approved symbol | ZBTB37 |
| Name | zinc finger and BTB domain containing 37 |
| Location | 1q25.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC2629, ZNF908 |
| Ensembl gene | ENSG00000185278 |
| Ensembl biotype | protein_coding |
| Entrez | 84614 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 8 protein_coding
ENST00000367701, ENST00000367702, ENST00000367704, ENST00000695459, ENST00000888347, ENST00000888348, ENST00000888349, ENST00000888350
RefSeq mRNA: 7 — MANE Select: NM_001122770
NM_001122770, NM_001346115, NM_001369846, NM_001395199, NM_001395201, NM_001395202, NM_032522
CCDS: CCDS1312, CCDS44278, CCDS86033
Canonical transcript exons
ENST00000367701 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001292509 | 173870200 | 173871148 |
| ENSE00001445419 | 173873467 | 173873566 |
| ENSE00001445423 | 173868925 | 173869120 |
| ENSE00001844940 | 173885636 | 173903547 |
| ENSE00003963877 | 173868380 | 173868405 |
Expression profiles
Bgee: expression breadth ubiquitous, 234 present calls, max score 87.95.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.9177 / max 57.4145, expressed in 1439 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 6749 | 3.5605 | 1382 |
| 6750 | 0.2855 | 140 |
| 6748 | 0.0718 | 22 |
Top tissues by expression
250 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 87.95 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.17 | gold quality |
| adrenal tissue | UBERON:0018303 | 81.49 | gold quality |
| corpus callosum | UBERON:0002336 | 81.04 | gold quality |
| sural nerve | UBERON:0015488 | 80.74 | gold quality |
| secondary oocyte | CL:0000655 | 79.36 | gold quality |
| calcaneal tendon | UBERON:0003701 | 79.10 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 78.34 | gold quality |
| thymus | UBERON:0002370 | 77.91 | gold quality |
| tendon | UBERON:0000043 | 77.07 | gold quality |
| blood | UBERON:0000178 | 75.85 | gold quality |
| bone marrow cell | CL:0002092 | 75.52 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 74.63 | gold quality |
| colonic epithelium | UBERON:0000397 | 74.32 | gold quality |
| cortical plate | UBERON:0005343 | 74.15 | gold quality |
| monocyte | CL:0000576 | 74.08 | gold quality |
| leukocyte | CL:0000738 | 73.94 | gold quality |
| superficial temporal artery | UBERON:0001614 | 73.54 | gold quality |
| testis | UBERON:0000473 | 73.40 | gold quality |
| skin of hip | UBERON:0001554 | 73.23 | gold quality |
| ganglionic eminence | UBERON:0004023 | 73.13 | gold quality |
| tibialis anterior | UBERON:0001385 | 73.10 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 72.76 | gold quality |
| ileal mucosa | UBERON:0000331 | 72.66 | gold quality |
| left testis | UBERON:0004533 | 72.65 | gold quality |
| adipose tissue | UBERON:0001013 | 72.64 | gold quality |
| right testis | UBERON:0004534 | 72.45 | gold quality |
| right lobe of liver | UBERON:0001114 | 72.35 | gold quality |
| ventricular zone | UBERON:0003053 | 72.22 | gold quality |
| tibial nerve | UBERON:0001323 | 72.16 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.30 |
| E-MTAB-7303 | no | 50.00 |
Regulation
Is transcription factor: no
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zbtb37 | ENSDARG00000042689 |
| mus_musculus | Zbtb37 | ENSMUSG00000043467 |
| rattus_norvegicus | Zbtb37 | ENSRNOG00000026907 |
Paralogs (36): ZNF302 (ENSG00000089335), ZNF184 (ENSG00000096654), CTCF (ENSG00000102974), ZNF574 (ENSG00000105732), ZBTB24 (ENSG00000112365), ZNF142 (ENSG00000115568), CTCFL (ENSG00000124092), ZNF473 (ENSG00000142528), ZNF827 (ENSG00000151612), ZNF689 (ENSG00000156853), ZNF208 (ENSG00000160321), ZNF91 (ENSG00000167232), ZNF526 (ENSG00000167625), ZNF764 (ENSG00000169951), ZNF747 (ENSG00000169955), ZNF282 (ENSG00000170265), ZNF160 (ENSG00000170949), ZNF497 (ENSG00000174586), ZBTB34 (ENSG00000177125), ZNF771 (ENSG00000179965), ZNF48 (ENSG00000180035), ZNF594 (ENSG00000180626), ZFP92 (ENSG00000189420), ZNF107 (ENSG00000196247), ZNF729 (ENSG00000196350), ZNF569 (ENSG00000196437), ZNF420 (ENSG00000197050), ZNF785 (ENSG00000197162), ZNF665 (ENSG00000197497), ZNF181 (ENSG00000197841), ZNF347 (ENSG00000197937), ZNF84 (ENSG00000198040), ZBTB48 (ENSG00000204859), ZNF845 (ENSG00000213799), ZNF99 (ENSG00000213973), ZNF688 (ENSG00000229809)
Protein
Protein identifiers
Zinc finger and BTB domain-containing protein 37 — Q5TC79 (reviewed: Q5TC79)
All UniProt accessions (1): Q5TC79
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5TC79-1 | 1 | yes |
| Q5TC79-2 | 2 | |
| Q5TC79-3 | 3 |
RefSeq proteins (7): NP_001116242, NP_001333044, NP_001356775, NP_001382128, NP_001382130, NP_001382131, NP_115911 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000210 | BTB/POZ_dom | Domain |
| IPR011333 | SKP1/BTB/POZ_sf | Homologous_superfamily |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050457 | ZnFinger_BTB_dom_contain | Family |
Pfam: PF00096, PF00651, PF12874
UniProt features (16 total): compositionally biased region 4, splice variant 3, zinc finger region 3, region of interest 3, chain 1, domain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5TC79-F1 | 56.20 | 0.07 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 156 (showing top):
HNF3ALPHA_Q6, AREB6_01, GGGTGGRR_PAX4_03, FOXD3_01, GOBP_CYTOKINE_PRODUCTION, IRF1_Q6, HFH8_01, TCF11_01, FOXJ2_01, HFH4_01, HFH3_01, HIF1_Q3, HFH1_01, AACTTT_UNKNOWN, FREAC4_01
GO Biological Process (3): negative regulation of transcription by RNA polymerase II (GO:0000122), regulation of cytokine production (GO:0001817), regulation of immune system process (GO:0002682)
GO Molecular Function (8): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227), zinc ion binding (GO:0008270), sequence-specific double-stranded DNA binding (GO:1990837), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (3): chromatin (GO:0000785), nucleoplasm (GO:0005654), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 3 |
| regulation of transcription by RNA polymerase II | 2 |
| cellular anatomical structure | 2 |
| transcription by RNA polymerase II | 1 |
| negative regulation of DNA-templated transcription | 1 |
| cytokine production | 1 |
| regulation of gene expression | 1 |
| regulation of multicellular organismal process | 1 |
| immune system process | 1 |
| regulation of biological process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| negative regulation of transcription by RNA polymerase II | 1 |
| DNA-binding transcription factor activity, RNA polymerase II-specific | 1 |
| DNA-binding transcription repressor activity | 1 |
| transition metal ion binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| chromosome | 1 |
| nuclear lumen | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
554 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZBTB37 | TEX50 | A0A1B0GTY4 | 643 |
| ZBTB37 | M0R1W7 | M0R1W7 | 592 |
| ZBTB37 | DARS2 | Q6PI48 | 543 |
| ZBTB37 | CENPL | Q8N0S6 | 539 |
| ZBTB37 | ANKRD45 | Q5TZF3 | 512 |
| ZBTB37 | KIAA0040 | Q15053 | 491 |
| ZBTB37 | THUMPD2 | Q9BTF0 | 449 |
| ZBTB37 | ZNF428 | Q96B54 | 448 |
| ZBTB37 | CFAP68 | Q9H5F2 | 447 |
| ZBTB37 | MPHOSPH6 | Q99547 | 438 |
| ZBTB37 | SLC9C2 | Q5TAH2 | 431 |
| ZBTB37 | RC3H1 | Q5TC82 | 413 |
| ZBTB37 | SMG7 | Q92540 | 398 |
| ZBTB37 | CHPF2 | Q9P2E5 | 393 |
| ZBTB37 | PIGC | Q92535 | 388 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FOXP3 | FOXP2 | psi-mi:“MI:0914”(association) | 0.530 |
| ZBTB37 | HSPB1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZBTB34 | CHEK1 | psi-mi:“MI:0914”(association) | 0.350 |
| ZBTB37 | SH3BP4 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (7): ZBTB37 (Two-hybrid), ZBTB37 (Affinity Capture-MS), ZBTB37 (Affinity Capture-RNA), ZBTB37 (Affinity Capture-MS), ZBTB37 (Affinity Capture-RNA), ZBTB37 (Proximity Label-MS), ZBTB37 (Two-hybrid)
ESM2 similar proteins: A0JN76, A1L2U9, B1WAZ8, B1WBU4, O15060, O35260, O43298, O93567, P14404, P41182, P41183, Q05516, Q0IH98, Q0IJ29, Q0P4X6, Q0V8G8, Q0VCJ6, Q15916, Q1L8W0, Q3B725, Q3SWU4, Q5TC79, Q5ZM39, Q6NRM8, Q6P882, Q6YND2, Q7TQG0, Q7TSZ8, Q7ZWZ4, Q801P1, Q80X44, Q86UZ6, Q8BID6, Q8CII0, Q8K088, Q8K0L9, Q8N680, Q8NAP8, Q8NCN2, Q8NCP5
Diamond homologs: A0A1B8YAB1, A1YPR0, B0WWP2, B1H285, B3M9V8, B3NDN0, B4GRJ2, B4HIK1, B4J045, B4L0G9, B4LIG6, B4MXW3, B4PD06, B4QLQ2, C9JR72, D3Z8N4, E0CZ16, G3X9X1, O15062, O88939, O93567, O95365, P28575, P41182, P41183, Q08CL3, Q08DK3, Q13105, Q16RL8, Q2M0J9, Q3UQV5, Q52KB5, Q5EXX3, Q5R7B8, Q5RDY3, Q5TC79, Q5ZI33, Q5ZKD9, Q5ZM39, Q60821
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
50 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 46 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
798 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:173870195:AGCAG:A | acceptor_gain | 1.0000 |
| 1:173870196:GCA:G | acceptor_gain | 1.0000 |
| 1:173870196:GCAGG:G | acceptor_gain | 1.0000 |
| 1:173885611:T:A | acceptor_gain | 1.0000 |
| 1:173885616:A:AG | acceptor_gain | 1.0000 |
| 1:173885617:T:G | acceptor_gain | 1.0000 |
| 1:173885625:A:AG | acceptor_gain | 1.0000 |
| 1:173885625:ACCT:A | acceptor_gain | 1.0000 |
| 1:173885625:ACCTG:A | acceptor_gain | 1.0000 |
| 1:173885626:C:G | acceptor_gain | 1.0000 |
| 1:173885628:T:TA | acceptor_gain | 1.0000 |
| 1:173885629:G:A | acceptor_gain | 1.0000 |
| 1:173885631:TACA:T | acceptor_loss | 1.0000 |
| 1:173885634:A:AG | acceptor_gain | 1.0000 |
| 1:173885634:AG:A | acceptor_gain | 1.0000 |
| 1:173885635:G:GT | acceptor_gain | 1.0000 |
| 1:173885635:GG:G | acceptor_gain | 1.0000 |
| 1:173885635:GGT:G | acceptor_gain | 1.0000 |
| 1:173885635:GGTA:G | acceptor_gain | 1.0000 |
| 1:173870191:TTTCA:T | acceptor_loss | 0.9900 |
| 1:173870192:TTCAG:T | acceptor_loss | 0.9900 |
| 1:173870193:TCAGC:T | acceptor_loss | 0.9900 |
| 1:173870195:A:AG | acceptor_gain | 0.9900 |
| 1:173870195:AG:A | acceptor_loss | 0.9900 |
| 1:173870196:G:GA | acceptor_gain | 0.9900 |
| 1:173870196:GC:G | acceptor_gain | 0.9900 |
| 1:173870323:A:AG | donor_gain | 0.9900 |
| 1:173870369:G:GA | donor_gain | 0.9900 |
| 1:173870421:A:G | donor_gain | 0.9900 |
| 1:173871033:G:GT | donor_gain | 0.9900 |
AlphaMissense
3315 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:173885735:T:C | C375R | 1.000 |
| 1:173885737:C:G | C375W | 1.000 |
| 1:173885746:C:G | C378W | 1.000 |
| 1:173885756:T:C | F382L | 1.000 |
| 1:173885758:C:A | F382L | 1.000 |
| 1:173885758:C:G | F382L | 1.000 |
| 1:173885781:G:C | R390P | 1.000 |
| 1:173885813:T:C | F401L | 1.000 |
| 1:173885815:C:A | F401L | 1.000 |
| 1:173885815:C:G | F401L | 1.000 |
| 1:173885819:T:C | C403R | 1.000 |
| 1:173885821:C:G | C403W | 1.000 |
| 1:173885840:T:G | Y410D | 1.000 |
| 1:173885847:G:C | R412P | 1.000 |
| 1:173885859:T:C | L416P | 1.000 |
| 1:173885868:A:C | H419P | 1.000 |
| 1:173885869:T:A | H419Q | 1.000 |
| 1:173885869:T:G | H419Q | 1.000 |
| 1:173885903:T:C | C431R | 1.000 |
| 1:173885905:T:G | C431W | 1.000 |
| 1:173885912:T:C | C434R | 1.000 |
| 1:173885924:T:C | F438L | 1.000 |
| 1:173885925:T:C | F438S | 1.000 |
| 1:173885926:C:A | F438L | 1.000 |
| 1:173885926:C:G | F438L | 1.000 |
| 1:173885930:T:C | F440L | 1.000 |
| 1:173885932:C:A | F440L | 1.000 |
| 1:173885932:C:G | F440L | 1.000 |
| 1:173885953:C:A | H447Q | 1.000 |
| 1:173885953:C:G | H447Q | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000052577 (1:173872226 G>C), RS1000056001 (1:173867389 G>A), RS1000069678 (1:173890212 T>A), RS1000127752 (1:173867669 A>G), RS1000247329 (1:173868599 C>G,T), RS1000405263 (1:173872428 A>G,T), RS1000450082 (1:173868415 G>A), RS1000471968 (1:173897024 T>A), RS1000500475 (1:173868214 T>G), RS1000607514 (1:173867847 G>A,C), RS1000640330 (1:173867622 A>C,G), RS1000763215 (1:173901485 C>G), RS1000770326 (1:173898696 A>G), RS1000836334 (1:173897353 T>C), RS1000907127 (1:173878038 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (1): cholesteatoma (MONDO:0006530)
Orphanet (0):
HPO phenotypes
1 total (1 of 1 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0009797 | Cholesteatoma |
GWAS associations
0 associations (top):
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| D002781 | Cholesteatoma | C17.800.428.260 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | decreases expression | 1 |
| FR900359 | affects phosphorylation | 1 |
| TAK-243 | increases sumoylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| perfluorooctanoic acid | increases expression | 1 |
| resorcinol | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Leflunomide | increases expression | 1 |
| Cadmium | increases expression, increases abundance | 1 |
| Dimethyl Sulfoxide | increases expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Urethane | increases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
16 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT01638052 | PHASE2 | COMPLETED | Great Auricular Nerve Block for Children Undergoing Tympanomastoid Surgery |
| NCT00270660 | Not specified | UNKNOWN | A Study of the Clinicopathologic Behaviour of the Different Types of Unsafe Chronic Otitis Media |
| NCT00682409 | Not specified | COMPLETED | Magnetic Resonance (MR) Imaging in the Post Operative Follow-up of Cholesteatoma in Children |
| NCT01855425 | Not specified | COMPLETED | Cone Beam CT for Diagnosis of Select Otorhinolaryngology (ENT) Indications at Lower Dose |
| NCT02019888 | Not specified | COMPLETED | Wide Frequency Band Test of Hearing in Veterans |
| NCT02903550 | Not specified | UNKNOWN | Usefulness of Non EPI-DWI-MRI / CT 3D Static Co-registration Prior to Surgery of Cholesteatomas |
| NCT03294421 | Not specified | UNKNOWN | Combined Access Closed Tympanomastoidectomy: Microsurgery Allied to Endoscopy |
| NCT03305796 | Not specified | UNKNOWN | Detection of Cholesteatoma Using Diffusion Magnetic Resonance Imaging |
| NCT03915392 | Not specified | UNKNOWN | Diffusion Weighted MRI Accuracy in Cholesteatoma Localization |
| NCT03954288 | Not specified | UNKNOWN | The Serum Sclerostin Levels in Cholesteatoma Patients |
| NCT04959539 | Not specified | COMPLETED | Endoscopic Transcanal Tympanoplasty With Attico-antrostomy Versus Endoscopic-assisted Canal Wall up Mastoidectomy in Management of Localized Cholesteatoma: A Randomized Clinical Trial |
| NCT05921643 | Not specified | RECRUITING | Short- and Medium-term Evaluation of Mastoid Filling Using Bioactive Glass |
| NCT06016335 | Not specified | COMPLETED | MRI-based Synthetic CT Images of the Head and Neck |
| NCT06268938 | Not specified | ACTIVE_NOT_RECRUITING | Outcomes of Mastoid Obliteration Canal Wall Down Tympanomastoidectomy in Cholesteatoma Surgery |
| NCT06424704 | Not specified | NOT_YET_RECRUITING | Chronic Suppurative Otitis Media Microbiology |
| NCT06738927 | Not specified | NOT_YET_RECRUITING | Otological Study of Facial Cleft Patients Over 10 Years of Age (Excluding Isolated Cleft Lip) (EFEOF) |
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): cholesteatoma